purpose of this study is to evaluate if Non-Hispanic Blacks (BLK) have higher readmission rates after cesarean delivery (CD) as compared to other races/ethnicities. STUDY DESIGN: Secondary analysis of a prospective multi-center study of women with a singleton gestation who delivered via primary or repeat CD and were readmitted within 6 weeks of delivery. Primary outcome was rate of hospital readmission within 6 weeks. Secondary outcome was rate of readmission for wound infection, hemorrhage and hypertension. A univariate analysis was performed to compare characteristics between the different racial/ethnic groups. A multivariate regression was then performed to adjust for socioeconomic factors and comorbidities likely to complicate postoperative course. RESULTS: Of the 50,928 cesarean sections, 675 (1.33%) patients were readmitted: 31.9% were Non-Hispanic White (WHT), 44.1% were BLK, 18.8% were Hispanic, and 5.2% were Other. Hospital readmissions were significantly higher in BLK when compared to WHT (aOR 1.76; 95% CI 1.82-2.58) but no differences were see in Hispanic (aOR 1.09; 95% CI 0.83-1.43) or Other groups (aOR 1.34; 95% CI 0.93-1.95) (see Table 1 ). Table 2 summarizes indications for readmission with the most common being wound infection at 43% (with and without separation) followed by abdominal infection (22%) and hypertension (14%). Hypertension was the only readmission indication significantly different between groups, BLK being more than WHT (20% vs. 11%, p<0.0001). CONCLUSION: The rate of readmission after CD and rate of HTN as indication for readmission was higher in Non-Hispanic Black population when compared to Non-Hispanic White even when controlling for socio-economic factors and comorbidities such as diabetes, hypertensive disorders of pregnancy, etc. The reason for these differences should be the subject of future studies.
OBJECTIVE: Human immunodeficiency virus (HIV) infection is a known risk factor for surgical site infection. However, women with HIV often have other risk factors for surgical site infection including tobacco use, illicit drug use, and limited primary care. We sought to examine risk factors for surgical site infection with focus on HIV infection. STUDY DESIGN: This was a retrospective cohort study of all women undergoing cesarean delivery at 23 weeks' gestation or greater, at an urban hospital, between 2012 and 2017. Women with missing data were excluded. The primary outcome was surgical site infection, defined as a composite of cellulitis, endometritis, deep wound infection, maternal sepsis and abdominopelvic abscess occurring up to 6 weeks after cesarean delivery. We used bivariable analyses to examine demographic and labor and delivery data. Outcomes with P <.05 by bivariable analyses were included in multivariable logistic regression models. Initial model compared women with HIV to women without HIV. Secondary analysis performed further categorizing women with HIV based on CD4-T lymphocyte counts ( 3 500 cells/microL, < 500 cells/microL, and unknown). RESULTS: Of the 6,912 women undergoing cesarean delivery, 372 (5.3%) had surgical site infections. Women with SSI were more likely to be older, nulliparous, non-Hispanic black, and have higher body mass index (kg/m 2 ), chronic hypertension, pregnancy-associated hypertension, no preoperative skin preparation due to emergency, vertical skin incision, staple skin closure, labor preceding to cesarean delivery, ruptured membranes, cesarean delivery during second stage, and HIV (all P <.05) ( Table 1) . These variables were included in the multivariable logistic regression. After adjusting for confounders, women with HIV had increased odds of surgical site infections compared to women without HIV (adjusted OR 2.52; 95% CI 1.31-4.88) ( Table 2 ). In the secondary analysis, women with HIV whose CD4-T lymphocyte counts 3 500 cells/microL had increased odds of surgical site infections compared to women without HIV infection (adjusted OR 2.48; 95%CI 1.02-6.03). CONCLUSION: In women undergoing cesarean delivery, we found women with HIV had increased odds of surgical site infections despite of the normal CD4-T lymphocyte counts. Due to the high risk for surgical site infection, these women may benefit from an early outpatient follow-up visit.
Poster Session V OBJECTIVE: To determine if a scheduled administrated of simethicone and metoclopramide as part of routine postoperative pain management regimens following cesarean delivery can decrease patient need for opiate analgesia following cesarean delivery. STUDY DESIGN: We conducted a prospective observational cohort study and followed all women receiving scheduled administrated of simethicone and metoclopramide as part of routine postoperative pain management regimens following cesarean delivery. These patients were compared to matched controls who did not receive scheduled administration of these drugs. Both groups received the same postoperative pain management regimen which included acetaminophen 1000mg PO every 6 hours, ketorolac 30mg IV for 8 doses followed by ibuprofen 600mg PO every 6 hours, and oxycodone 5mg PO every 6 hours as needed for moderate pain and 10mg PO every 6 hours as needed for severe pain. The control group was ordered for ondansetron 4mg IV as needed for nausea whereas the simethicone/metoclopramide group received metoclopramide 10mg IV every 6 hours. Simethicone was ordered as 160mg PO every 6 hours for the intervention group. Inclusion criteria included patients with pfannestiel surgical incisions and low transverse cesarean deliveries. Patients were excluded if they required a vertical skin incision, a classical cesarean delivery, and/or additional procedures intraoperatively at time of cesarean delivery. RESULTS: The study included 88 patients, with 44 patients in each arm. When compared with the control regimen group, the simethicone/metoclopramide regimen group had lower rates of opiate use 39.9% (95% CI 31.7-45.4) versus 46.8% (95% CI 41.1-49.0), p ¼ 0.013. The simethicone/metoclopramide group also demonstrated a decreased length of hospital stay when compared with the control group with an average hospital stay of 3.1AE0.5 (2-4) versus 3.9AE0.8 (2-6), p ¼ 0.001. After adjusting for BMI, diabetes mellitus, gestational blood pressure >140/90, group b-Streptococcus status, race, advanced maternal age (>34 y), and parity, this difference was still preserved for lower opiate use and decreased hospital stay, p ¼ 0.02 and p ¼ 0.05 respectively. There was no difference in rates of postoperative ileus or small bowel obstruction. CONCLUSION: By simply administering scheduled dosing of simethicone and metoclopramide following cesarean deliveries, the use of opiates and extended postoperative hospital stays can potentially be mitigated. OBJECTIVE: Safe prevention of primary Cesarean delivery (CD) is a priority in modern obstetric practice, and appropriate case selection for operative vaginal delivery (OVD) is key. OVD rates (especially forceps) are declining in the US and nowadays mainly comprise direct, low/outlet extractions. In other countries where rates of successful/safe OVD are significantly higher, e.g. the UK, proven competence in mid-cavity/rotational OVD is a prerequisite for
